China Medicine Corporation (CHME)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
At close: May 30, 2025

China Medicine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2009 FY 2008 FY 2007 FY 2006 FY 2005 2003 - 2004
Period Ending
May '25 Dec '09 Dec '08 Dec '07 Dec '06 Dec '05 2003 - 2004
Market Capitalization
066114223-
Upgrade
Market Cap Growth
67.01%500.88%-74.05%87.05%--
Upgrade
Enterprise Value
-6793921-
Upgrade
Last Close Price
0.004.300.722.853.06-
Upgrade
PE Ratio
-38.351.206.144.72-
Upgrade
PS Ratio
0.001.020.201.000.94-
Upgrade
PB Ratio
0.001.450.251.331.59-
Upgrade
P/TBV Ratio
0.002.330.261.421.72-
Upgrade
P/FCF Ratio
0.004.877.11---
Upgrade
P/OCF Ratio
0.003.882.61---
Upgrade
EV/Sales Ratio
-1.040.170.930.88-
Upgrade
EV/EBITDA Ratio
-5.060.804.472.91-
Upgrade
EV/EBIT Ratio
-5.480.844.642.97-
Upgrade
EV/FCF Ratio
-4.975.91---
Upgrade
Debt / Equity Ratio
0.030.21---0.02
Upgrade
Debt / EBITDA Ratio
0.300.72---0.02
Upgrade
Debt / FCF Ratio
0.630.70---0.10
Upgrade
Asset Turnover
0.701.161.391.782.393.44
Upgrade
Inventory Turnover
6.3312.288.7810.169.158.07
Upgrade
Quick Ratio
2.971.5820.4022.4812.344.38
Upgrade
Current Ratio
11.152.1031.1834.0920.798.76
Upgrade
Return on Equity (ROE)
6.63%3.15%23.90%29.52%50.23%166.44%
Upgrade
Return on Assets (ROA)
7.82%13.75%17.67%22.18%44.25%75.94%
Upgrade
Return on Capital (ROIC)
8.15%15.55%18.12%22.89%46.75%95.18%
Upgrade
Return on Capital Employed (ROCE)
9.30%23.40%25.10%26.50%50.20%110.90%
Upgrade
Earnings Yield
-1579.63%2.61%83.24%16.28%21.20%-
Upgrade
FCF Yield
89635.63%20.52%14.07%-6.39%-13.48%-
Upgrade
Buyback Yield / Dilution
-107.86%-0.67%-12.08%-78.45%-17.21%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.